Dr. Babatunde Akinsete is interested in the medical complications of oncologic diseases and investigating novel management approaches. He also plans to participate in an effort to minimize healthcare disparities through promoting and counseling at risk patients about preventative measures and early screening modalities for early detection of cancer.
Dr. Deniz Dayicioglu is a plastic and reconstructive surgeon at Moffitt Cancer Center and The University of South Florida. She sees female patients with cancer-related reconstructive needs in The Center for Women’s Oncology. She is committed to providing exceptional aesthetic outcomes and personalized care for women with breast cancer.
Dr. Mohammad Hussaini’s clinical interests are in the diagnosis and categorization of malignant hematologic conditions, particularly acute leukemias and non-Hodgkin lymphoma. His research focus is in investigating, identifying, and assaying for molecular markers in acute leukemia and lymphoma using molecular techniques, particularly next-generation sequencing, to actualize the potential of personalized medicine in hematologic malignancies.
Dr. Frank Vrionis is a leading spine surgeon recognized for his expertise in benign and malignant tumors of the brain and spinal cord. He is chief of neurosurgery at Moffitt Cancer, as well as director of Moffitt’s Complex Spine and Skull Base Surgery Program and the Spine Research Laboratory. He is the founder and director of Moffitt’s Spine Oncology Fellowship Program for physician-scientists pursuing advanced education in this medical specialty.
Dr. Shahzad is a gynecologic oncologist in The Center for Women’s Oncology. Dr. Shahzad's clinical interests are in the surgical management of advanced gynecologic malignancies, including cytoreductive surgery for ovarian cancer, complex minimally invasive laparoscopic and robotic surgery for endometrial and cervical cancers as well as fertility sparing surgical techniques.
Dr. David Shibata is a Surgical Oncologist and Chief of the Section of Colorectal Oncology in the Gastrointestinal Oncology Department at Moffitt Cancer Center where he has been since 2004. He is Professor of Surgery and Oncology at the University of South Florida College of Medicine. He is particularly interested in laparoscopic/minimally invasive approaches to the treatment of colorectal cancer as well as sphincter-preserving techniques for patients with rectal cancer.
Dr. Nam Tran is a neuro-oncology surgeon at Moffitt Cancer Center and assistant professor of oncology and neurosurgery at the University of South Florida College of Medicine. Dr. Tran’s research interests include regulation of the blood brain barrier, tumor and trauma-associated cerebral edema, central nervous system malignancies and spine biomechanics. He has received advanced training in minimally invasive spine techniques and artificial disc replacement surgery.
Dr. Basil Cherpelis is a dermatologist in the Department of Cutaneous Oncology at Moffitt Cancer. He is an associate professor in the Departments of Dermatology and Oncologic Sciences at the University of South Florida College of Medicine. Dr. Cherpelis’ research and clinical interests include melanoma and other skin cancers. He is a specialist in Mohs surgery, an advanced procedure for skin cancer removal.
Dr. William Dalton is the CEO of M2Gen, a Moffitt Cancer Center biotechnology company. Additionally, he is founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s brand of personalized medicine, Total Cancer Care®. Dr. Dalton served as president and CEO of Moffitt from 2002 to 2012 and was instrumental in helping the Cancer Center achieve tremendous growth and innovation.